by Robert Johnston | Jul 12, 2023 | Vaccines
A Fresh Look at Vaccines Returning to First Principles Clarus Biologics, Inc. Clarus Biologics is developing a two component vaccine/immunology strategy. Component One: A virus-like particle (VLP) which sends a strong non-specific activation signal to the immune...
Recent Comments